Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Tilkin

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Pediatric Surgery|October 1, 1977
Gastrostomy closure: a quick, easy, and safe methodJ C Ducharme, S Youssef, F Tilkin
Gastroenterologie Clinique Et Biologique|February 15, 2001
[Tumor escape mechanism involving Fas and Fas-L molecules in human colorectal tumors]S Radfar, H Martin, A F Tilkin-Mariame
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cellsA F Tilkin, E Gomard, B Begue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Natural suppressor cell inhibiting T killer responses against retroviruses: a model for self toleranceA F Tilkin, B Bègue, E Gomard, et al.
The Journal of Experimental Medicine|December 1, 1981
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytesF Plata, A F Tilkin, J P Lévy, et al.
Immunological Reviews|August 1, 1990
Autoreactive HLA-DR-specific autoreactive T-cell clones: possible regulatory function for B lymphocytes and hematopoietic precursorsA F Tilkin, G Vinci, J Michon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patientA F Tilkin, M Bagot, M Kayibanda, et al.
Human Immunology|July 1, 1997
Differential binding to frequent HLA-A alleles of p21 RAS derived peptides bearing oncogenic substitutions at position 12 or 13C Gouttefangeas, C Demeur, F Connan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cellsA F Tilkin, N Schaaf-Lafontaine, A Van Acker, et al.
Leukemia Research|January 1, 1986
B cells from leukemic patients are relatively resistant to in-vitro EBV transformationA F Tilkin, M Bagot, F Picard, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Pediatric Surgery|October 1, 1977
Gastrostomy closure: a quick, easy, and safe methodJ C Ducharme, S Youssef, F Tilkin
Gastroenterologie Clinique Et Biologique|February 15, 2001
[Tumor escape mechanism involving Fas and Fas-L molecules in human colorectal tumors]S Radfar, H Martin, A F Tilkin-Mariame
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cellsA F Tilkin, E Gomard, B Begue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1985
Natural suppressor cell inhibiting T killer responses against retroviruses: a model for self toleranceA F Tilkin, B Bègue, E Gomard, et al.
The Journal of Experimental Medicine|December 1, 1981
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytesF Plata, A F Tilkin, J P Lévy, et al.
Immunological Reviews|August 1, 1990
Autoreactive HLA-DR-specific autoreactive T-cell clones: possible regulatory function for B lymphocytes and hematopoietic precursorsA F Tilkin, G Vinci, J Michon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1986
A human autoreactive T cell line specific for minor histocompatibility antigen(s) isolated from a bone marrow-grafted patientA F Tilkin, M Bagot, M Kayibanda, et al.
Human Immunology|July 1, 1997
Differential binding to frequent HLA-A alleles of p21 RAS derived peptides bearing oncogenic substitutions at position 12 or 13C Gouttefangeas, C Demeur, F Connan, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1981
Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cellsA F Tilkin, N Schaaf-Lafontaine, A Van Acker, et al.
Leukemia Research|January 1, 1986
B cells from leukemic patients are relatively resistant to in-vitro EBV transformationA F Tilkin, M Bagot, F Picard, et al.
Pageof 2